Join us for an insightful webinar exploring Lonza's comprehensive portfolio of primary human cells and optimized media systems.
Discover how these foundational tools empower researchers to develop advanced, complex in vitro models that deliver improved biological relevancy and predictive power. Lonza scientists will guide attendees through applications in angiogenesis research, from simple qualitative screening approaches to sophisticated co-culture models enabling precise quantitative analysis.
In the second half of the session, our collaborator Aracari Biosciences will present their cutting-edge vascularized organ and tumor chips. These innovative platforms offer physiologically relevant environments that accelerate drug development by providing more accurate and meaningful results.
Whether you're advancing disease modeling or optimizing drug screening, this webinar will provide valuable insights into building more predictive and translational in vitro systems.
Presenters

Scott Kelsey
Scott joined Lonza in January 2023 as a project manager and marketing content developer for the Biosciences Cell Discovery team. He obtained his Masters of Science from Ohio State University (USA) in 2016, and later found his calling in scientific project management. He has co-authored two technical notes on angiogenesis using human umbilical vein endothelial cells that can be found on the Lonza website.

Christopher Hughes
Dr. Hughes is also Chancellor’s Professor of Molecular Biology & Biochemistry, and Biomedical Engineering at UC Irvine. Dr. Hughes’ research focuses on the development and growth of blood vessels and spans multiple scales – from understanding the basic molecular mechanisms of angiogenesis, to engineering of artificial tissues. Recently his lab has been pioneering “Body-on-Chip” technology, which allows for micro-organs to be grown on a “chip”, each with its own blood vessel network. Tissues generated include liver, pancreas, lung, various tumors and brain, including a blood-brain barrier. These devices are gaining use as screening tools for new therapeutic drugs, and the technology, co-developed by two co-founders Dr. Steve George and Dr. Abe Lee, is now licensed to Aracari Biosciences. Dr. Hughes has published over 130 peer-reviewed manuscripts, and in 2014 was elected a Fellow of the American Association for the Advancement of Science (AAAS).
Sponsor

Lonza Bioscience
Content Partners

Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

































































































